ALKS-1140

N/A

Report date: 2022/12/09 16:22:14
NME

Base Information

Drug NameALKS-1140
Drug Alias NameALKS-1140
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase 2 inhibitorsHistone deacetylase 1 inhibitors
TargetsHistone deacetylase 2Histone deacetylase 1
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlkermes Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlkermes Inc
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A